Condensed Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenue	$ 470	$ 1,003
Cost of revenues	18	158
Gross profit	452	845
Operating expenses:
Sales and marketing expenses	6	15
General and administrative expenses	188	603
Research and development costs	48	177
Operating income	210	50
Gain (loss) from change in fair value of hybrid financial instruments	(1,515)	(545)
Gain (loss) from change in fair value of derivative liability - warrants	(1)	373
Gain (loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	5	137
Interest expense	(19)	0
Net income (loss)	$ (1,320)	$ 15
Net income (loss) per common share:
Basic (in dollars per share)	$ 0.000	$ 0.000
Fully diluted (in dollars per share)	$ 0.000	$ 0.000
Weighted average number of common shares:
Basic (in shares)	4,506,555,811	4,984,827,279
Fully diluted (in shares)	4,506,555,811	266,001,250,808